{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:33:51Z","timestamp":1787020431629,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-024-01664-8","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T05:02:17Z","timestamp":1722920537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Arginine vasopressin deficiency onset after COVID-19 vaccination with positive anti-rabphilin-3A antibodies: a case report and literature review"],"prefix":"10.1186","volume":"24","author":[{"given":"Hiroki","family":"Takizawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoyoshi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Watada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"issue":"10","key":"1664_CR1","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1210\/clinem\/dgac381","volume":"107","author":"M Tomkins","year":"2022","unstructured":"Tomkins M, Lawless S, Martin-Grace J, Sherlock M, Thompson CJ. Diagnosis and management of Central Diabetes Insipidus in adults. J Clin Endocrinol Metab. 2022;107(10):2701\u201315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1664_CR2","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1038\/s41598-022-08552-y","volume":"12","author":"Z Arihara","year":"2022","unstructured":"Arihara Z, Sakurai K, Niitsuma S, Sato R, Yamada S, Inoshita N, Iwata N, Fujisawa H, Watanabe T, Suzuki A, et al. Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center. Sci Rep. 2022;12(1):4440.","journal-title":"Sci Rep"},{"issue":"2","key":"1664_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/idr14020023","volume":"14","author":"SA Mirza","year":"2022","unstructured":"Mirza SA, Sheikh AAE, Barbera M, Ijaz Z, Javaid MA, Shekhar R, Pal S, Sheikh AB. COVID-19 and the Endocrine System: a review of the current information and misinformation. Infect Dis Rep. 2022;14(2):184\u201397.","journal-title":"Infect Dis Rep"},{"issue":"2","key":"1664_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12020-022-03119-3","volume":"78","author":"Y Zhao","year":"2022","unstructured":"Zhao Y. X Wu 2022 Influence of COVID-19 vaccines on endocrine system. Endocrine 78 2 241\u20136.","journal-title":"Endocrine"},{"issue":"4","key":"1664_CR5","doi-asserted-by":"publisher","first-page":"a2576","DOI":"10.1016\/j.chest.2020.09.172","volume":"158","author":"H Rajevac","year":"2020","unstructured":"Rajevac H, Bachan M, Khan Z. Diabetes insipidus as a Symptom of Covid-19 infection: Case Report. Chest. 2020;158(4):a2576\u20132576.","journal-title":"Chest"},{"key":"1664_CR6","doi-asserted-by":"crossref","first-page":"232470962199995","DOI":"10.1177\/2324709621999954","volume":"9","author":"AB Sheikh","year":"2021","unstructured":"Sheikh AB, Javed N, Sheikh AAE, Upadhyay S, Shekhar R. Diabetes insipidus and concomitant myocarditis: a late sequelae of COVID-19 infection. J Investig Med High Impact Case Rep. 2021;9:2324709621999954.","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"12","key":"1664_CR7","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1007\/s40618-021-01627-z","volume":"44","author":"RA Misgar","year":"2021","unstructured":"Misgar RA, Rasool A, Wani AI, Bashir MI. Central diabetes insipidus (Infundibuloneuro hypophysitis): a late complication of COVID-19 infection. J Endocrinol Invest. 2021;44(12):2855\u20136.","journal-title":"J Endocrinol Invest"},{"key":"1664_CR8","first-page":"222","volume":"38","author":"AB Sheikh","year":"2021","unstructured":"Sheikh AB, Javaid MA, Sheikh AAE, Shekhar R. Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report. Pan Afr Med J. 2021;38:222.","journal-title":"Pan Afr Med J"},{"issue":"1","key":"1664_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12902-022-01048-w","volume":"22","author":"A Yavari","year":"2022","unstructured":"Yavari A, Sharifan Z, Larijani B, Mosadegh Khah A. Central diabetes insipidus secondary to COVID-19 infection: a case report. BMC Endocr Disord. 2022;22(1):134.","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"1664_CR10","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1097\/INF.0000000000003632","volume":"41","author":"M Lizzi","year":"2022","unstructured":"Lizzi M, Arico M, Carlone G, Anzellotti MT, Trotta D, Palatino V. Central Diabetes Insipidus: another rare complication of SARS-CoV-2 infection in children? Pediatr Infect Dis J. 2022;41(10):e448.","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"1664_CR11","first-page":"e43884","volume":"15","author":"S Suresh Kumar","year":"2023","unstructured":"Suresh Kumar S, Kumar K, Venkataramani S, Ghazi NM. Central Diabetes Insipidus: an Acute Manifestation of COVID-19 infection. Cureus. 2023;15(8):e43884.","journal-title":"Cureus"},{"key":"1664_CR12","doi-asserted-by":"crossref","first-page":"232470962110433","DOI":"10.1177\/23247096211043386","volume":"9","author":"N Murvelashvili","year":"2021","unstructured":"Murvelashvili N, Tessnow A. A case of Hypophysitis following immunization with the mRNA-1273 SARS-CoV-2 vaccine. J Investig Med High Impact Case Rep. 2021;9:23247096211043386.","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"5","key":"1664_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.aace.2022.06.001","volume":"8","author":"AR Ankireddypalli","year":"2022","unstructured":"Ankireddypalli AR, Chow LS, Radulescu A, Kawakami Y, Araki T. A case of Hypophysitis Associated with SARS-CoV-2 vaccination. AACE Clin Case Rep. 2022;8(5):204\u20139.","journal-title":"AACE Clin Case Rep"},{"key":"1664_CR14","doi-asserted-by":"publisher","first-page":"889074","DOI":"10.3389\/fendo.2022.889074","volume":"13","author":"B Bouca","year":"2022","unstructured":"Bouca B, Roldao M, Bogalho P, Cerqueira L, Silva-Nunes J. Central Diabetes Insipidus following immunization with BNT162b2 mRNA COVID-19 vaccine: a Case Report. Front Endocrinol (Lausanne). 2022;13:889074.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1664_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.therap.2022.09.007","volume":"78","author":"T Ach","year":"2023","unstructured":"Ach T, Kammoun F, Fekih HE, Slama NBH, Kahloun S, Fredj FB, Laouani C, Ach K. Central diabetes insipidus revealing a hypophysitis induced by SARS-CoV-2 vaccine. Therapie. 2023;78(4):453\u20135.","journal-title":"Therapie"},{"issue":"1","key":"1664_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12902-023-01296-4","volume":"23","author":"A Ishay","year":"2023","unstructured":"Ishay A, Shacham EC. Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine? BMC Endocr Disord. 2023;23(1):47.","journal-title":"BMC Endocr Disord"},{"key":"1664_CR17","doi-asserted-by":"publisher","first-page":"1166953","DOI":"10.3389\/fendo.2023.1166953","volume":"14","author":"C Partenope","year":"2023","unstructured":"Partenope C, Pedranzini Q, Petri A, Rabbone I, Prodam F, Bellone S. AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: a case report. Front Endocrinol (Lausanne). 2023;14:1166953.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1664_CR18","doi-asserted-by":"publisher","first-page":"232470962311860","DOI":"10.1177\/23247096231186046","volume":"11","author":"T Matsuo","year":"2023","unstructured":"Matsuo T, Okubo K, Mifune H, Imao T. Bilateral Optic Neuritis and Hypophysitis with Diabetes Insipidus 1 Month after COVID-19 mRNA vaccine: Case Report and Literature Review. J Investig Med High Impact Case Rep. 2023;11:23247096231186046.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"1664_CR19","doi-asserted-by":"crossref","unstructured":"Johnston PC, Chew LS, Hamrahian AH, Kennedy L. Lymphocytic infundibulo-neurohypophysitis: a clinical overview. Endocr 2015, 50(3):531\u20136.","DOI":"10.1007\/s12020-015-0707-6"},{"issue":"3","key":"1664_CR20","first-page":"198","volume":"100","author":"KC Sheen","year":"2001","unstructured":"Sheen KC, Chang CC, Chang TC, Liu HM. Thickened pituitary stalk with central diabetes insipidus: report of three cases. J Formos Med Assoc. 2001;100(3):198\u2013204.","journal-title":"J Formos Med Assoc"},{"issue":"7","key":"1664_CR21","doi-asserted-by":"publisher","first-page":"E946","DOI":"10.1210\/jc.2014-4209","volume":"100","author":"S Iwama","year":"2015","unstructured":"Iwama S, Sugimura Y, Kiyota A, Kato T, Enomoto A, Suzuki H, Iwata N, Takeuchi S, Nakashima K, Takagi H, et al. Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis. J Clin Endocrinol Metab. 2015;100(7):E946\u2013954.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1664_CR22","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1210\/jc.2013-3724","volume":"99","author":"N Di Iorgi","year":"2014","unstructured":"Di Iorgi N, Allegri AE, Napoli F, Calcagno A, Calandra E, Fratangeli N, Vannati M, Rossi A, Bagnasco F, Haupt R, et al. Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. J Clin Endocrinol Metab. 2014;99(4):1264\u201372.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1664_CR23","doi-asserted-by":"publisher","first-page":"101412","DOI":"10.1016\/j.beem.2020.101412","volume":"34","author":"NL Bragazzi","year":"2020","unstructured":"Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y. ASIA syndrome and endocrine autoimmune disorders. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101412.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"1664_CR24","first-page":"454","volume":"22","author":"Z Checinska","year":"1966","unstructured":"Checinska Z, Galazka A, Smolik R. [A case of diabetes insipidus after smallpox vaccination]. Przegl Lek. 1966;22(6):454\u20135.","journal-title":"Przegl Lek"},{"issue":"5","key":"1664_CR25","first-page":"242","volume":"29","author":"I Palmar","year":"1972","unstructured":"Palmar I, Kaljalovic R, Popovic M, Marcetic V. [Encephalopathy after vaccination against smallpox with permanent sequel\u2013diabetes insipidus]. Vojnosanit Pregl. 1972;29(5):242\u20134.","journal-title":"Vojnosanit Pregl"},{"key":"1664_CR26","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","volume":"217","author":"A Vojdani","year":"2020","unstructured":"Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217:108480.","journal-title":"Clin Immunol"},{"issue":"2","key":"1664_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271\u201380. e278.","journal-title":"Cell"},{"issue":"11","key":"1664_CR28","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1021\/acschemneuro.0c00265","volume":"11","author":"F Chigr","year":"2020","unstructured":"Chigr F, Merzouki M, Najimi M. Autonomic Brain centers and Pathophysiology of COVID-19. ACS Chem Neurosci. 2020;11(11):1520\u20132.","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"1664_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13730-022-00769-0","volume":"12","author":"A Ohashi","year":"2023","unstructured":"Ohashi A, Takeda Y, Watada M, Ihara F, Oshita T, Iwata N, Fujisawa H, Suzuki A, Sugimura Y, Maeda Y. Central diabetes insipidus with anti-rabphilin-3A antibody positivity causing hypovolemic shock after resection of tumorous lesions in the pelvic cavity. CEN Case Rep. 2023;12(3):297\u2013303.","journal-title":"CEN Case Rep"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01664-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01664-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01664-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:02:28Z","timestamp":1722963748000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01664-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1664"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01664-8","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not necessary for the reported investigations, as they were performed in a routine clinical setting and therapeutic intention. Written informed consent was obtained from the patient before undergoing all clinical procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Written informed consent was obtained from the parents of the study participants. A copy of the written consent is available for review by the Editor of this journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no COIs to disclose in this report.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}